Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neumología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency
INTERVENTIONAL
Inicio: 1 de nov de 2013
ID: NCT01983241
Completado
ClinicalTrials.gov
Risk Assessment of Ventilator-induced Lung Injury in Patients With Acute Respiratory Distress Syndrome: The Role of Morphological Phenotype in ARDS
OBSERVATIONAL
Inicio: 7 de ago de 2017
ID: NCT04157946
Activo, no recluta
Fase 3
ClinicalTrials.gov
PROCLAIM: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Chemotherapy for Treatment of Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
INTERVENTIONAL
Inicio: 26 de feb de 2020
ID: NCT03937154
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study, to Investigate the Efficacy and Safety of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
INTERVENTIONAL
Inicio: 17 de sept de 2025
ID: NCT07190222
Completado
Fase 2
ClinicalTrials.gov
A Study to Learn How Well the Drug Larotrectinib Works in Adults With Different Solid Cancers With a Change in the Genes Called NTRK Fusion
INTERVENTIONAL
Inicio: 30 de sept de 2015
ID: NCT02576431
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Multi-center, Open Label Study of NIR178 in Combination With PDR001 in Patients With Selected Advanced Solid Tumors and Non-Hodgkin Lymphoma
INTERVENTIONAL
Inicio: 28 de ago de 2017
ID: NCT03207867
Completado
Fase 3
ClinicalTrials.gov
A Multicentre, Randomized, Double-blind, Parallel Group, Placebocontrolled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Asthmatic Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist (CALIMA)
INTERVENTIONAL
Inicio: 1 de ago de 2013
ID: NCT01914757
Terminado
Fase 2
ClinicalTrials.gov
A Participant- and Investigator-blinded, Randomized, Placebo-controlled, Multicenter, Platform Study to Investigate Efficacy, Safety, and Tolerability of Various Single Treatments in Participants With Idiopathic Pulmonary Fibrosis
INTERVENTIONAL
Inicio: 10 de nov de 2022
ID: NCT05497284
Desconocido
ClinicalTrials.gov
Association Between Testosterone Levels and COPD Severity Measured by BODE Index in Men
OBSERVATIONAL
Inicio: 1 de jun de 2016
ID: NCT02824809
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants With Pulmonary Fibrosis
INTERVENTIONAL
Inicio: 29 de jul de 2020
ID: NCT04308681
Reclutando
Fase 3
ClinicalTrials.gov
Phase 3 Study of Pembrolizumab in Combination With Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab With or Without Maintenance MK-2870 in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer
INTERVENTIONAL
Inicio: 10 de jun de 2024
ID: NCT06422143
Completado
Fase 4
ClinicalTrials.gov
MAESTRAL - A Prospective, Multinational, Multicenter, Randomized, Double Blind, Double Dummy, Controlled Study Comparing the Efficacy and Safety of Moxifloxacin to That of Amoxicillin Clavulanic Acid for the Treatment of Subjects With Acute Exacerbations of Chronic Bronchitis.
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00656747
Completado
Fase 3
ClinicalTrials.gov
A Phase 3b, Non-randomized, Open Label, Multi-country, Cohort Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies (RSV MAT-001, RSV MAT-004, RSV MAT-010, RSV MAT-011, RSV MAT-009, RSV MAT-012 and RSV MAT-039) During Any Pregnancy Conceived Post Vaccination/Control
INTERVENTIONAL
Inicio: 7 de feb de 2023
ID: NCT05705440
Completado
Fase 3
ClinicalTrials.gov
Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)
INTERVENTIONAL
Inicio: 30 de ago de 2016
ID: NCT02566993
Completado
Fase 3
ClinicalTrials.gov
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
INTERVENTIONAL
Inicio: 30 de abr de 2014
ID: NCT02106832
Completado
Fase 2
ClinicalTrials.gov
A Multi-Centre, Multinational, Randomized, Double-Blind, Placebo Controlled, Proof Of Concept Trial To Assess The Effects Of A Subject-Optimized Dose Of UK-369,003 On Exercise Capacity In Subjects With Chronic Obstructive Pulmonary Disease
INTERVENTIONAL
Inicio: 1 de dic de 2004
ID: NCT00163098
Completado
Fase 4
ClinicalTrials.gov
A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline Versus Ceftriaxone Plus Vancomycin in Pediatric Subjects With Complicated Community-acquired Bacterial Pneumonia (CABP)
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01669980
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Active-controlled, Parallel Group, Stratified, Multi-center, 12-Week Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™ 250/10ug Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI) With the Administration of Fluticasone (250ug Twice Daily) Alone in SkyePharma HFA pMDI and Flovent® HFA pMDI in Adolescent and Adult Patients With Moderate to Severe Asthma
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00649025
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
INTERVENTIONAL
Inicio: 25 de oct de 2023
ID: NCT06025578
Completado
Fase 3
ClinicalTrials.gov
Randomised, Double-blind, Double-dummy, Parallel-group, Comparative Study of Salmeterol/FP 50/100mcg bd Inhalation Powder Via Diskus With Oral Montelukast (5mg QD) Chewable Tablets in Children 6-14 Years
INTERVENTIONAL
Inicio: 1 de oct de 2005
ID: NCT00328718
Anterior
1
...
35
36
37
...
434
Siguiente
Filtros